IQVIA_Rules_Based_Medicine_Logo - rgb

(+01) 512 835 8026

Email us

Type your search term and press "enter."

Tumor Necrosis Factor Receptor I

Tumor Necrosis Factor Receptor I

Tumor Necrosis Factor Receptor I (TNFRI) is a 55 kDa pleiotropic cytokine that is considered a primary modifier of the inflammatory and immune reactions of animals produced in response to injury or infection. It is the receptor for TNFSF2; TNF-alpha and homotrimeric TNFSFI/lymphotoxin-alpha. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation and initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. It also contributes to the induction of non-cytocidal TNF effects including anti-viral state and activation of the acid sphingomyelinase.

Swiss-Prot Accession Number: P19438


Bibliography

High cytomegalovirus serology and subsequent COPD-related mortality: a longitudinal study (2020) Nenna R, Zhai J, Packard SE, Spangenberg A, Sherrill DL, Martinez FD, Halonen M, Guerra S ERJ Open Research

medical_services Therapy Indications

Serum kidney injury molecule 1 and B2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes (2018) Colombo M, Looker HC, Farran B, Hess S, Groop L, Palmer CNA, Brosnan MJ, Dalton RN, Wong M, Turner C, Ahlqvist E, Dunger D, Agakov F, Durrington P, Livingstone S, Betteridge J, McKeigue PM, Colhoun HM Diabetologia

medical_services Therapy Indications